Glutamine supplementation in critically ill patients

Laura Pasin, Pasquale Nardelli, Desiderio Piras

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Glutamine supplementation in intensive care unit patients is supposed to improve outcome by modulating inflammatory response, preventing organ injury, modulating glucose metabolism and inducing cellular protection pathways. Trials showed conflicting results on mortality. Heyland et al showed a significant increase in mortality in critically ill patients who received glutamine supplementation. Their results were confirmed by a subsequent meta-analysis considering only high quality evidence. Therefore, glutamine supplementation should be avoided in this setting.

Original languageEnglish
Title of host publicationReducing Mortality in Critically Ill Patients
PublisherSpringer International Publishing
Pages117-122
Number of pages6
ISBN (Print)9783319175157, 9783319175140
DOIs
Publication statusPublished - Jan 1 2015

Fingerprint

Glutamine
Critical Illness
Mortality
Intensive Care Units
Meta-Analysis
Glucose
Wounds and Injuries

Keywords

  • Critically ill
  • Glutamine
  • Mortality

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Pasin, L., Nardelli, P., & Piras, D. (2015). Glutamine supplementation in critically ill patients. In Reducing Mortality in Critically Ill Patients (pp. 117-122). Springer International Publishing. https://doi.org/10.1007/978-3-319-17515-7_15

Glutamine supplementation in critically ill patients. / Pasin, Laura; Nardelli, Pasquale; Piras, Desiderio.

Reducing Mortality in Critically Ill Patients. Springer International Publishing, 2015. p. 117-122.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pasin, L, Nardelli, P & Piras, D 2015, Glutamine supplementation in critically ill patients. in Reducing Mortality in Critically Ill Patients. Springer International Publishing, pp. 117-122. https://doi.org/10.1007/978-3-319-17515-7_15
Pasin L, Nardelli P, Piras D. Glutamine supplementation in critically ill patients. In Reducing Mortality in Critically Ill Patients. Springer International Publishing. 2015. p. 117-122 https://doi.org/10.1007/978-3-319-17515-7_15
Pasin, Laura ; Nardelli, Pasquale ; Piras, Desiderio. / Glutamine supplementation in critically ill patients. Reducing Mortality in Critically Ill Patients. Springer International Publishing, 2015. pp. 117-122
@inbook{35e55a11354548d0b381b636a0648437,
title = "Glutamine supplementation in critically ill patients",
abstract = "Glutamine supplementation in intensive care unit patients is supposed to improve outcome by modulating inflammatory response, preventing organ injury, modulating glucose metabolism and inducing cellular protection pathways. Trials showed conflicting results on mortality. Heyland et al showed a significant increase in mortality in critically ill patients who received glutamine supplementation. Their results were confirmed by a subsequent meta-analysis considering only high quality evidence. Therefore, glutamine supplementation should be avoided in this setting.",
keywords = "Critically ill, Glutamine, Mortality",
author = "Laura Pasin and Pasquale Nardelli and Desiderio Piras",
year = "2015",
month = "1",
day = "1",
doi = "10.1007/978-3-319-17515-7_15",
language = "English",
isbn = "9783319175157",
pages = "117--122",
booktitle = "Reducing Mortality in Critically Ill Patients",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Glutamine supplementation in critically ill patients

AU - Pasin, Laura

AU - Nardelli, Pasquale

AU - Piras, Desiderio

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Glutamine supplementation in intensive care unit patients is supposed to improve outcome by modulating inflammatory response, preventing organ injury, modulating glucose metabolism and inducing cellular protection pathways. Trials showed conflicting results on mortality. Heyland et al showed a significant increase in mortality in critically ill patients who received glutamine supplementation. Their results were confirmed by a subsequent meta-analysis considering only high quality evidence. Therefore, glutamine supplementation should be avoided in this setting.

AB - Glutamine supplementation in intensive care unit patients is supposed to improve outcome by modulating inflammatory response, preventing organ injury, modulating glucose metabolism and inducing cellular protection pathways. Trials showed conflicting results on mortality. Heyland et al showed a significant increase in mortality in critically ill patients who received glutamine supplementation. Their results were confirmed by a subsequent meta-analysis considering only high quality evidence. Therefore, glutamine supplementation should be avoided in this setting.

KW - Critically ill

KW - Glutamine

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=84943370682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943370682&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-17515-7_15

DO - 10.1007/978-3-319-17515-7_15

M3 - Chapter

AN - SCOPUS:84943370682

SN - 9783319175157

SN - 9783319175140

SP - 117

EP - 122

BT - Reducing Mortality in Critically Ill Patients

PB - Springer International Publishing

ER -